Navegar por los elementos (6 total)

• A Novel Approach to Infectious Disease Preparedness: Incorporating Investigational Therapeutics and Research Objectives into Full-Scale Exercises

  Etiquetas Exercises and Drills, Experimental Drugs, R-Res&Pub, Research, Therapeutics
  Autor: Angela Vasa, Syra Madad, LuAnn Larson, Colleen S. Kraft, Sharon Vanairsdale, Jonathan D. Grein, Jennifer Garland, Virginia “Madison” Butterworth, and Christopher J. Kratochvil.
  Tema: Research
  Tipo de elemento: Publicación
  Fecha de actualización: 2019-02-19
  Descripción: The use of investigational therapeutics in the care of patients with Ebola virus disease was documented in the literature following the 2013-2016 outbreak. In order to access these types of therapeutics, facilities must have processes in place to…

• Are We Ready for the Next Outbreak?

  Etiquetas Ebola, Epidemic, Epidemiology, Experimental Drugs, Federal, International Response, Medical Surveillance, Outbreaks, Pandemic, Prophylaxis, Public Health, R-Gen
  Autor: U.S. Agency for International Development
  Tema: General
  Tipo de elemento: Webinar
  Fecha de actualización: 2018-04-01
  Descripción: A three part pod-cast series discusses the need for new and improved tools to fight infectious disease, as demonstrated by the recent outbreaks of Ebola and Zika.

• Products Approved for Other Bioterrorism Emergencies

  Etiquetas Ebola, Experimental Drugs, MERS-CoV, Orthopox Virus, Plague, Prophylaxis, R-T&C, Respiratory Pathogen, Smallpox, Special Pathogens, Therapeutics, Viral Hemorrhagic Fever
  Autor: U.S. Food and Drug Administration
  Tema: Treatment & Care
  Tipo de elemento: Guía
  Fecha de actualización: 2017-09-08
  Descripción: This site lists products for Botulism due to Clostridium botulinum toxin; Ebola Virus Disease (EVD); Glanders and Melioidosis due to Burkholderia mallei and B. pseudomallei, respectively; Plague due to Yersinia pestis; Smallpox due to Variola major…
• 

  After the Ebola Outbreak: Lessons Learned

  Etiquetas Critical Care, Ebola, Experimental Drugs, Follow up, Infection Prevention and Control, Nursing, Patient Care, Personal Protective Equipment (PPE), Prophylaxis, R-PPE, Survivors, Therapeutics, Training, Translational Research
  Autor: Loftus, Mary (editor), Emory Medicine
  Tema: General
  Tipo de elemento: Hipervínculo
  Fecha de actualización: 2018-02-20
  Descripción: In the wake of caring for four patients with active Ebola virus in 2014, Emory clinicians have taken stock of lessons learned in infectious disease prevention, therapeutic care, and health aftereffects and are sharing that information broadly with…
• 

  The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States

  Etiquetas Critical Care, Ebola, Experimental Drugs, Patient Care, R-Res&Pub, Therapeutics
  Autor: Kraft, C. S., A. L. Hewlett, S. Koepsell, A. M. Winkler, C. J. Kratochvil, L. Larson, J. B. Varkey, A. K. Mehta, G. M. Lyon, 3rd, R. J. Friedman-Moraco, V. C. Marconi, C. E. Hill, J. N. Sullivan, D. W. Johnson, S. J. Lisco, M. J. Mulligan, T. M.…
  Tema: Research
  Tipo de elemento: Publicación
  Fecha de actualización: 2015-08-15
  Descripción: The current West Africa Ebola virus disease (EVD) outbreak has resulted in multiple individuals being medically evacuated to other countries for clinical management.
• 

  Editorial Commentary: Considerations of Favipiravir as a Medical Countermeasure in Future Randomized Controlled Trials Against Ebola Virus Disease

  Etiquetas Clinical Trial, Ebola, Experimental Drugs, Patient Care, R-Res&Pub, Therapeutics
  Autor: Kraft, C. S.
  Tema: Research
  Tipo de elemento: Publicación
  Fecha de actualización: 2016-11-15
  Descripción: Since the discovery of Ebola virus in the Democratic Republic of Congo in 1976, outbreaks of EVD had been mainly confined to rural areas (http://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html)...